scholarly article | Q13442814 |
P2093 | author name string | Sasaki MS | |
Ishizaki K | |||
Sugimoto M | |||
Toguchida J | |||
Yamamuro T | |||
Ikenaga M | |||
Kotoura Y | |||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | retinoblastoma | Q500695 |
P304 | page(s) | 3939-3943 | |
P577 | publication date | 1988-07-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma | |
P478 | volume | 48 |
Q40562591 | Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene |
Q73429863 | Allelic Losses from Chromosome 17 in Human Osteosarcomas |
Q48067523 | Alterations of the p53, Rb and MDM2 genes in osteosarcoma |
Q70524574 | Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone |
Q47759057 | Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas |
Q35753196 | CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations |
Q35975873 | Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies |
Q35034142 | Chromosomal localization of putative tumor-suppressor genes in several human cancers |
Q77482360 | Clinicopathologiclmplications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors |
Q34793401 | Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma |
Q35889404 | Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis |
Q30541684 | Distal deletion of chromosome Ip in ductal carcinoma of the breast |
Q36038523 | Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line |
Q41640482 | Inactivation of p53 gene in human and murine osteosarcoma cells |
Q36954453 | Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage |
Q33851092 | Mitotic recombination of chromosome 17 in astrocytomas |
Q40468269 | Molecular Genetics and Cytogenetics of Sarcomas |
Q41591490 | Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F |
Q39997545 | No evidence of microsatellite instability in bone tumours |
Q37474150 | Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering |
Q26782646 | Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies |
Q33725511 | Osteosarcoma Overview |
Q36803600 | Osteosarcoma development and stem cell differentiation |
Q38487040 | Osteosarcoma in identical twins: A case report |
Q36080738 | Retinoblastoma gene mutations in primary human bladder cancer |
Q34725035 | Retinoblastoma gene structure and product expression in human gastric carcinomas |
Q42452984 | Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells |
Q34246832 | Role of the retinoblastoma gene in the initiation and progression of human cancer |
Q34286847 | Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene |
Q41526922 | Strategies for Approaching Retinoblastoma Tumor Suppressor Gene Therapy |
Q36467187 | Structural alterations of the RB1 gene in human soft tissue tumours |
Q27630171 | Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen |
Q41528803 | The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis |
Q70117697 | The genetics of retinoblastoma |
Q38306731 | The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator |
Q36816438 | The retinoblastoma gene product regulates Sp1-mediated transcription |
Q24337366 | Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen |
Search more.